Suchergebnisse - "Ghanaatgar-Kasbi, Sadaf"

PubPharm (6)

1

Targeting the Transforming Growth Factor-beta Signaling Pathway in the Treatment of Gynecologic Cancer

enthalten in: Current cancer drug targets | 2022

von Ghanaatgar-Kasbi, S. | Pouya, F. | Khoshghamat, N. | +5

2

The Therapeutic Potential of MEK1/2 Inhibitors in the Treatment of Gynecological Cancers : Rational Strategies and Recent Progress

enthalten in: Current cancer drug targets | 2020

von Ghanaatgar-Kasbi, S. | Khazaei, M. | Rastgar-Moghadam, A. | +3

3

AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway

enthalten in: IUBMB life | 2019

von Ghanaatgar-Kasbi, S. | Amerizadeh, F. | Rahmani, F. | +4

4

AMP‐kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway

enthalten in: IUBMB Life | 2019

von Ghanaatgar‐Kasbi, S. | Amerizadeh, F. | Rahmani, F. | +4

5

Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal Adenocarcinoma

enthalten in: Current pharmaceutical design | 2018

von Ghanaatgar-Kasbi, S. | Khorrami, S. | Avan, A. | +2

6

Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal Adenocarcinoma

enthalten in: Current pharmaceutical design | 2018

von Ghanaatgar-Kasbi, S. | Khorrami, S. | Avan, A. | +2

1
[1]